{"id":29753,"date":"2025-08-08T06:01:29","date_gmt":"2025-08-08T06:01:29","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/wcc-biomedicalnacds-total-store-expo-advancing-microneedle-drug-delivery-with-winmap-platform\/"},"modified":"2025-08-08T06:01:29","modified_gmt":"2025-08-08T06:01:29","slug":"wcc-biomedicalnacds-total-store-expo-advancing-microneedle-drug-delivery-with-winmap-platform","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=29753","title":{"rendered":"WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP\u2122 Platform"},"content":{"rendered":"

TAIPEI<\/span><\/span>, Aug. 8, 2025<\/span><\/span> \/PRNewswire\/ — WCC Biomedical<\/a>, a leader in novel drug delivery systems, will attend the upcoming NACDS Total Store Expo<\/a> (TSE), where it will spotlight its proprietary WINMAP\u2122 microarray patch (MAP) technology and launch two new products.<\/p>\n

\n

\"Chairman <\/a>
Chairman of Synmosa biopharma group, Peter Lin (Second from the left), and Chiarman of WCC biomedical, Dr. TJ Liu (Second to the right) celebrate the sucess debut of WCC biomedical.<\/span><\/p>\n<\/div>\n

To explore WINMAP\u2122 technology for vaccines and pharmaceuticals, join WCC at the Total Store Expo on August 23\u201325 in San Diego, CA<\/span>: Booth # 900<\/u><\/b><\/p>\n

Following a successful debut at BIO Asia in Taiwan<\/span> (July 23\u201327), WCC will offer demonstrations of its new products at TSE, allowing attendees to witness the benefits of microneedle-based patch solutions for themselves. Its two new MAP products are a homeopathic pain-relief patch and a herbal MACA patch, both available via the standard dissolvable WINMAP platform. WCC will exhibit at TSE alongside its key partner and investor, Synmosa<\/a> Group, a leading specialty pharmaceutical company in Taiwan<\/span>.<\/p>\n

“Our WINMAP\u2122 platform sets a new standard for producing microneedles \u2014 with an unprecedented combination of high-precision molds, accurate drug loading, and efficient, scalable mass production,” remarked Ta-Jo Liu<\/span>, Chairman and CEO of WCC Biomedical. “With this first-in-class platform, we aim to demonstrate how MAPs can expand possibilities for nutrition and pharmaceuticals with needle-free, painless delivery.”<\/p>\n

Precision, scale, and consistency with WINMAP\u2122<\/b><\/p>\n

A next-generation drug delivery system, WINMAP\u2122 uses micrometer-scale needles made of medical-grade polymers to deliver active ingredients painlessly through the skin \u2014without the need for any kind of injection. The technology leverages a combination of penetration, dissolution, diffusion, and formulation to deliver active ingredients more effectively than traditional transdermal patches or topical creams.<\/p>\n

Key features include:<\/p>\n